Insufficient scRNA-seq data for expression of H2BC19P at single-cell level.
Insufficient scRNA-seq data for expression of H2BC19P at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 95% | 10.64 | 232 / 245 | 86% | 3.17 | 432 / 502 |
| esophagus | 87% | 5.93 | 1264 / 1445 | 84% | 2.66 | 154 / 183 |
| ovary | 91% | 7.21 | 163 / 180 | 77% | 2.26 | 329 / 430 |
| lung | 90% | 8.90 | 523 / 578 | 70% | 1.73 | 804 / 1155 |
| breast | 73% | 4.69 | 334 / 459 | 85% | 3.30 | 948 / 1118 |
| stomach | 84% | 5.19 | 303 / 359 | 65% | 1.66 | 186 / 286 |
| uterus | 91% | 9.03 | 155 / 170 | 56% | 1.31 | 259 / 459 |
| intestine | 89% | 6.72 | 861 / 966 | 55% | 1.07 | 288 / 527 |
| bladder | 90% | 6.57 | 19 / 21 | 52% | 1.37 | 262 / 504 |
| skin | 83% | 5.57 | 1509 / 1809 | 56% | 1.33 | 262 / 472 |
| brain | 63% | 3.85 | 1674 / 2642 | 64% | 1.57 | 451 / 705 |
| thymus | 85% | 5.26 | 555 / 653 | 40% | 0.87 | 242 / 605 |
| pancreas | 62% | 2.34 | 203 / 328 | 56% | 1.21 | 100 / 178 |
| adrenal gland | 74% | 3.62 | 190 / 258 | 30% | 0.47 | 68 / 230 |
| spleen | 95% | 10.41 | 229 / 241 | 0% | 0 | 0 / 0 |
| kidney | 63% | 3.34 | 56 / 89 | 32% | 0.60 | 285 / 901 |
| blood vessel | 90% | 7.32 | 1201 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 81% | 7.55 | 752 / 929 | 0% | 0 | 0 / 0 |
| liver | 46% | 1.51 | 104 / 226 | 22% | 0.47 | 91 / 406 |
| heart | 62% | 2.65 | 538 / 861 | 0% | 0 | 0 / 0 |
| adipose | 62% | 2.91 | 746 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 0.71 | 13 / 29 |
| muscle | 42% | 1.39 | 339 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 36% | 0.54 | 29 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 18% | 0.35 | 8 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000786 | Cellular component | nucleosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0003677 | Molecular function | DNA binding |
| GO_0030527 | Molecular function | structural constituent of chromatin |
| Gene name | H2BC19P |
| Protein name | Putative histone H2B type 2-D (H2B-clustered histone 19 pseudogene) |
| Synonyms | HIST2H2BD |
| Description | FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
| Accessions | Q6DRA6 |